Takeda Pharmaceutical Net Income 2012-2025 | TAK

Takeda Pharmaceutical annual/quarterly net income history and growth rate from 2012 to 2025. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.

Takeda Pharmaceutical net income for the quarter ending September 30, 2025 was $0M, a 100% decline year-over-year.
Takeda Pharmaceutical net income for the twelve months ending September 30, 2025 was $1.421B, a 10.4% increase year-over-year.
Takeda Pharmaceutical annual net income for 2025 was $0.712B, a 28.34% decline from 2024.
Takeda Pharmaceutical annual net income for 2024 was $0.994B, a 57.63% decline from 2023.
Takeda Pharmaceutical annual net income for 2023 was $2.346B, a 14.57% increase from 2022.

Takeda Pharmaceutical Annual Net Income (Millions of US $)
2025	$712
2024	$994
2023	$2,346
2022	$2,048
2021	$3,534
2020	$407
2019	$982
2018	$1,682
2017	$1,069
2016	$665
2015	$-1,327
2014	$1,067
2013	$1,588
2012	$1,577
2011	$2,986

Takeda Pharmaceutical Quarterly Net Income (Millions of US $)
2025-09-30
2025-06-30	$857
2024-06-30	$610
2024-03-31	$-46
2023-12-31	$719
2023-09-30	$-331
2023-06-30	$653
2023-03-31	$247
2022-12-31	$846
2022-09-30	$445
2022-06-30	$809
2022-03-31	$-703
2021-12-31	$508
2021-09-30	$418
2021-06-30	$1,823
2021-03-31	$1,843
2020-12-31	$887
2020-09-30	$38
2020-06-30	$767
2020-03-31	$391
2019-12-31	$-296
2019-09-30	$501
2019-06-30	$-188
2018-12-31	$336
2018-06-30	$720
2017-06-30	$1,303
2016-06-30	$926
2015-06-30	$202
2015-03-31	$-1,892
2014-12-31	$156
2014-09-30	$260
2014-06-30	$326
2014-03-31	$-43
2013-12-31	$457
2013-09-30	$360
2013-06-30	$296
2013-03-31	$462
2012-12-31	$236
2012-09-30	$409
2012-06-30	$1,119
2012-03-31	$-460
2011-12-31	$322
2011-09-30	$775
2011-03-31	$394

Sector	Industry	Market Cap	Revenue
Medical	Medical - Drug Manufacturing	$50.943B	$30.087B
Takeda Pharmaceutical Company Limited operates as a research-based pharmaceutical company, engaged in manufacturing, marketing, and importing/exporting pharmaceutical drugs. Takeda's core business comprise of ethical drugs and its portfolio includes lansoprazole for the treatment of peptic ulcers, leuprolide acetate for the treatment of prostate cancer and endometriosis, pioglitazone hydrocholoride for the treatment of diabetes, and candesartan cilexetil for the treatment of hypertension. The Company promotes enhancing R&D pipeline, while concentrating its management resources to the four core therapeutic areas: lifestyle-related diseases, oncology and urological diseases, central nervous system disease and gastroenterological diseases. It operates in two segments- Ethical drug business and Consumer healthcare business. Consumer healthcare business provides Alinamin (vitamin B1 derivative preparations, etc.), Benza (cold remedies). Takeda Pharmaceutical Company Limited is headquartered in Osaka, Japan.

Stock Name	Country	Market Cap	PE Ratio
Chugai Pharmaceutical (CHGCY)	Japan	$87.245B	33.14
Zoetis (ZTS)	United States	$54.919B	19.66
Daiichi Sankyo, - (DSNKY)	Japan	$42.301B	21.07
BeOne Medicines - (ONC)	Switzerland	$38.498B	204.10
Sandoz Group AG (SDZNY)	Switzerland	$32.476B	0.00
United Therapeutics (UTHR)	United States	$20.532B	18.07
Merck (MKKGY)	Germany	$19.360B	11.94
Shionogi (SGIOY)	Japan	$15.432B	14.17
Neurocrine Biosciences (NBIX)	United States	$13.187B	31.64
Summit Therapeutics (SMMT)	United States	$12.963B	0.00
Ionis Pharmaceuticals (IONS)	United States	$12.874B	0.00
IPSEN (IPSEY)	France	$12.596B	0.00
Madrigal Pharmaceuticals (MDGL)	United States	$11.217B	0.00
Orion OYJ (ORINY)	Finland	$10.204B	29.15
Eisai (ESAIY)		$8.586B	0.00
Ono Pharmaceutical (OPHLF)	Japan	$6.576B	20.00
Stevanato Group S.p.A (STVN)	Italy	$6.178B	34.58
Grifols, S.A (GRFS)	Spain	$6.078B	0.00
Crinetics Pharmaceuticals (CRNX)	United States	$5.154B	0.00
Hikma Pharmaceuticals Plc (HKMPF)	United Kingdom	$4.613B	0.00
Indivior (INDV)	United States	$4.251B	17.35
AMNEAL PHARMACEUTICALS, INC (AMRX)	United States	$4.077B	19.36
Corcept Therapeutics (CORT)	United States	$3.824B	41.31
NewAmsterdam Pharma (NAMS)	Netherlands	$3.613B	0.00
Centessa Pharmaceuticals (CNTA)	United Kingdom	$2.987B	0.00
Hypermarcas (HYPMY)	Brazil	$2.784B	19.11
Catalyst Pharmaceuticals (CPRX)	United States	$2.747B	8.76
Dyne Therapeutics (DYN)	United States	$2.434B	0.00
Soleno Therapeutics (SLNO)	United States	$2.230B	0.00
Ocular Therapeutix (OCUL)	United States	$2.222B	0.00
Avadel Pharmaceuticals (AVDL)	Ireland	$2.098B	0.00
Guardian Pharmacy Services (GRDN)	United States	$1.979B	38.12
Aurinia Pharmaceuticals Inc (AUPH)	Canada	$1.976B	23.42
Harrow (HROW)	United States	$1.748B	107.25
Ardelyx (ARDX)	United States	$1.711B	0.00
Enliven Therapeutics (ELVN)	United States	$1.528B	0.00
Oruka Therapeutics (ORKA)	United States	$1.517B	0.00
Collegium Pharmaceutical (COLL)	United States	$1.495B	7.40
BioCryst Pharmaceuticals (BCRX)	United States	$1.422B	84.38
Amylyx Pharmaceuticals (AMLX)	United States	$1.384B	0.00
Relay Therapeutics (RLAY)	United States	$1.376B	0.00
Evotec AG (EVO)	Germany	$1.374B	0.00
Xeris Biopharma Holdings (XERS)	United States	$1.279B	0.00
Savara (SVRA)	United States	$1.205B	0.00
ARS Pharmaceuticals (SPRY)	United States	$1.118B	0.00
Cronos Group (CRON)	Canada	$1.032B	0.00
Theravance Biopharma (TBPH)	United States	$1.030B	43.26
Xencor (XNCR)	United States	$0.995B	0.00
Esperion Therapeutics (ESPR)	United States	$0.789B	0.00
KalVista Pharmaceuticals (KALV)	United States	$0.755B	0.00
Ironwood Pharmaceuticals (IRWD)	United States	$0.755B	17.85
Nektar Therapeutics (NKTR)	United States	$0.744B	0.00
Rigel Pharmaceuticals (RIGL)	United States	$0.689B	6.15
ProKidney (PROK)	United States	$0.689B	0.00
Bioventus (BVS)	United States	$0.637B	13.05
Lexeo Therapeutics (LXEO)	United States	$0.542B	0.00
Organogenesis (ORGO)	United States	$0.518B	0.00
Elite Pharmaceuticals (ELTP)	United States	$0.516B	0.00
Lyell Immunopharma (LYEL)	United States	$0.504B	0.00
Zevra Therapeutics (ZVRA)	United States	$0.502B	0.00
Siga Technologies (SIGA)	United States	$0.473B	6.47
4D Molecular Therapeutics (FDMT)	United States	$0.449B	0.00
Altimmune (ALT)	United States	$0.418B	0.00
Aquestive Therapeutics (AQST)	United States	$0.417B	0.00
Nature's Sunshine Products (NATR)	United States	$0.392B	23.34
USANA Health Sciences (USNA)	United States	$0.371B	10.36
Akebia Therapeutics (AKBA)	United States	$0.366B	0.00
Avalo Therapeutics (AVTX)	United States	$0.318B	0.00
Profound Medical (PROF)	Canada	$0.304B	0.00
Relmada Therapeutics (RLMD)	United States	$0.298B	0.00
Achieve Life Sciences (ACHV)	Canada	$0.294B	0.00
Aclaris Therapeutics (ACRS)	United States	$0.294B	0.00
Silence Therapeutics (SLN)	United Kingdom	$0.279B	0.00
Larimar Therapeutics (LRMR)	United States	$0.276B	0.00
Fractyl Health (GUTS)	United States	$0.275B	0.00
OmniAb (OABI)	United States	$0.274B	0.00
Heron Therapeutics (HRTX)	United States	$0.271B	0.00
Protara Therapeutics (TARA)	United States	$0.254B	0.00
Aldeyra Therapeutics (ALDX)	United States	$0.249B	0.00
Journey Medical (DERM)	United States	$0.217B	0.00
Enlivex Therapeutics (ENLV)	Israel	$0.210B	0.00
Galectin Therapeutics (GALT)	United States	$0.198B	0.00
Tonix Pharmaceuticals Holding (TNXP)	United States	$0.190B	0.00
Century Therapeutics (IPSC)	United States	$0.188B	0.00
Minerva Neurosciences (NERV)	United States	$0.185B	0.00
MediWound (MDWD)	Israel	$0.183B	0.00
Innate Pharma SA (IPHYF)	France	$0.181B	0.00
Surrozen (SRZN)	United States	$0.177B	0.00
AleAnna (ANNA)	United States	$0.168B	0.00
Procaps Group, S.A (PROCF)	Luxembourg	$0.161B	0.00
Karyopharm Therapeutics (KPTI)	United States	$0.145B	0.00
Prelude Therapeutics (PRLD)	United States	$0.141B	0.00
Corbus Pharmaceuticals Holdings (CRBP)	United States	$0.139B	0.00
Context Therapeutics (CNTX)	United States	$0.138B	0.00
Incannex Healthcare (IXHL)	Australia	$0.132B	0.00
Unicycive Therapeutics (UNCY)	United States	$0.130B	0.00
Verrica Pharmaceuticals (VRCA)	United States	$0.128B	0.00
VAXART, INC (VXRT)	United States	$0.127B	0.00
Inhibikase Therapeutics (IKT)	United States	$0.126B	0.00
Pyxis Oncology (PYXS)	United States	$0.117B	0.00
Avita Medical (RCEL)	United States	$0.101B	0.00
Cassava Sciences (SAVA)	United States	$0.099B	0.00
Champions Oncology (CSBR)	United States	$0.098B	41.50
Cardiol Therapeutics (CRDL)	Canada	$0.097B	0.00
Vivani Medical (VANI)	United States	$0.093B	0.00
Gain Therapeutics (GANX)	United States	$0.086B	0.00
Korro Bio (KRRO)	United States	$0.085B	0.00
PolyPid (PYPD)	Israel	$0.070B	0.00
Cumberland Pharmaceuticals (CPIX)	United States	$0.070B	58.50
Dominari Holdings (DOMH)	United States	$0.068B	0.00
Assertio Holdings (ASRT)	United States	$0.066B	0.00
Plus Therapeutics (PSTV)	United States	$0.065B	0.00
Arch Biopartners (ACHFF)	Canada	$0.065B	0.00
Metagenomi (MGX)	United States	$0.065B	0.00
Rafael Holdings (RFL)	United States	$0.064B	0.00
NRx Pharmaceuticals (NRXP)	United States	$0.063B	0.00
PMV Pharmaceuticals (PMVP)	United States	$0.062B	0.00
Lipocine (LPCN)	United States	$0.058B	0.00
Lite Strategy (LITS)	United States	$0.055B	0.00
Acrivon Therapeutics (ACRV)	United States	$0.054B	0.00
Nutriband (NTRB)	United States	$0.052B	0.00
ElectroCore (ECOR)	United States	$0.050B	0.00
Talphera (TLPH)	United States	$0.048B	0.00
Telomir Pharmaceuticals (TELO)	United States	$0.046B	0.00
Reviva Pharmaceuticals Holdings (RVPH)	United States	$0.041B	0.00
FibroGen (FGEN)	United States	$0.039B	0.00
Wellgistics Health (WGRX)	United States	$0.038B	0.00
FibroGen (KYNB)	United States	$0.037B	0.00
Mural Oncology (MURA)	Ireland	$0.035B	0.00
Jupiter Neurosciences (JUNS)	United States	$0.032B	0.00
MARKER THERAPEUTICS, INC (MRKR)	United States	$0.029B	0.00
Natural Alternatives (NAII)	United States	$0.028B	0.00
SCYNEXIS (SCYX)	United States	$0.028B	0.00
TherapeuticsMD (TXMD)	United States	$0.024B	0.00
Klotho Neurosciences (KLTO)	United States	$0.024B	0.00
Scienture Holdings (SCNX)	United States	$0.022B	0.00
Inotiv (NOTV)	United States	$0.021B	0.00
Liminatus Pharma (LIMN)	United States	$0.021B	0.00
VYNE Therapeutics (VYNE)	United States	$0.019B	0.00
Iterum Therapeutics (ITRM)	Ireland	$0.018B	0.00
Citius Pharmaceuticals (CTXR)	United States	$0.018B	0.00
Vyome Holdings (HIND)	United States	$0.018B	0.00
Vivos Therapeutics (VVOS)	United States	$0.018B	0.00
Cosmos Health (COSM)	United States	$0.018B	0.00
Mannatech (MTEX)	United States	$0.014B	0.00
Tempest Therapeutics (TPST)	United States	$0.013B	0.00
Traws Pharma (TRAW)	United States	$0.013B	0.02
CASI Pharmaceuticals (CASI)	China	$0.013B	0.00
Phio Pharmaceuticals (PHIO)	United States	$0.013B	0.00
BioLineRx (BLRX)	Israel	$0.012B	0.00
China SXT Pharmaceuticals (SXTC)	China	$0.012B	0.00
Addex Therapeutics (ADXN)	Switzerland	$0.011B	0.00
Curanex Pharmaceuticals Inc (CURX)	United States	$0.010B	0.00
Mangoceuticals (MGRX)	United States	$0.010B	0.00
Ernexa Therapeutics (ERNA)	United States	$0.010B	0.00
BioVie (BIVI)	United States	$0.010B	0.00
XTL Biopharmaceuticals (XTLB)	Israel	$0.009B	0.00
Nuvilex (PMCB)	United States	$0.009B	0.00
Ainos (AIMD)	United States	$0.009B	0.00
Quoin Pharmaceuticals (QNRX)	United States	$0.009B	0.00
Kiora Pharmaceuticals (KPRX)	United States	$0.008B	0.00
Biomerica (BMRA)	United States	$0.008B	0.00
Salarius Pharmaceuticals (DCOY)	United States	$0.008B	0.00
TransCode Therapeutics (RNAZ)	United States	$0.008B	0.00
Heatwurx (PCSA)	United States	$0.007B	0.00
Aptorum Group (APM)	United Kingdom	$0.007B	0.00
Indaptus Therapeutics (INDP)	United States	$0.006B	0.00
Redhill Biopharma (RDHL)	Israel	$0.006B	0.00
Alaunos Therapeutics (TCRT)	United States	$0.006B	0.00
Sonoma Pharmaceuticals (SNOA)	United States	$0.006B	0.00
Xenetic Biosciences (XBIO)	United States	$0.005B	0.00
Salarius Pharmaceuticals (SLRX)	United States	$0.005B	0.00
XORTX Therapeutics (XRTX)	Canada	$0.004B	0.00
Clearmind Medicine (CMND)	Canada	$0.004B	0.00
Lyra Therapeutics (LYRA)	United States	$0.004B	0.00
InMed Pharmaceuticals (INM)	Canada	$0.003B	0.00
Jaguar Animal Health (JAGX)	United States	$0.003B	0.00
Universe Pharmaceuticals INC (UPC)	China	$0.002B	0.00
Shuttle Pharmaceuticals Holdings (SHPH)	United States	$0.002B	0.00
CDT Equity (CDT)	United States	$0.002B	0.00
60 Degrees Pharmaceuticals (SXTP)	United States	$0.002B	0.00
PainReform (PRFX)	Israel	$0.002B	0.00
Galmed Pharmaceuticals (GLMD)	Israel	$0.001B	0.00
SciSparc (SPRC)	Israel	$0.001B	0.00
Aditxt (ADTX)	United States	$0.001B	0.00
Emisphere Technologies (EMIS)	United States	$0.000B	0.00
4D Pharma (LBPS)	United Kingdom	$0.000B	0.00
Patheon (PTHN)	Netherlands	$0.000B	0.00
RVL Pharmaceuticals (RVLP)	United States	$0.000B	0.00